Lyme Disease: Are we Close to an Effective Diagnostic Test?
Though the most common tick-related infection, Lyme disease is easy to treat, but hard to diagnose. Virax Biolabs is aiming to change that.
Category: Allergy & Autoimmune
Allergy & Autoimmune
Latest
Allergy & Autoimmune
Latest
Rheumatoid Arthritis: From Misdiagnosis to Precision Diagnosis
Thermo Fisher's Phadia Laboratory Systems enhance the precision and speed of diagnosing autoimmune diseases, such as rheumatoid arthritis.
Allergy & Autoimmune
Latest
New Test Method Improves Detection of Emerging Tick-Borne Virus
The emerging Powassan virus in ticks can cause life-threatening neuroinvasive disease, including encephalitis and meningitis.Â
Mayo Clinic Labs and Progentec Collaborate on Advanced Biomarker Tests for Autoimmune Diseases
Mayo Clinic’s new collaboration will bring Progentec’s suite of biomarker blood tests for the management of autoimmune diseases to market.Â
Read More
Genetic Biomarker May Predict Severity of Food Allergy
Researchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.Â
Read More
Researchers Harness AI to Help Diagnose Lupus Nephritis
Researchers from the University of Houston are working to bring AI into the diagnostic picture for Lupus Nephritis.
Read More
Possible Biomarker of MS-Like Disease Discovered
Researchers at the University of Basel and the University Hospital of Basel described a possible new MS-like disease and how to diagnose it.
Read More
Novel Method Diagnoses Infant Atopic Dermatitis with Sebum
The noninvasive method diagnoses atopic dermatitis by analyzing RNA from samples of sebum collected from infants using an oil-blotting film.
Read More
Progentec and GSK Collab on Virtual Lupus Diagnostics
Progentec launched a study with GSK aimed at identifying people at risk of developing lupus and guiding their virtual diagnostic journey.
Read More
For Antiphospholipid Syndrome Lab Results Don’t Always Tell Full Story
Patients with antiphospholipid syndrome are given different medications to reduce their risk of blood clotting and help normalize lab values.
Read More
New Virus Discovered in Swiss Ticks
Researchers from the University of Zurich (UZH) have now detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
Read More
Early Genetic Testing Predict Heart Disease, Novel Therapies for Women with Lupus
AMPEL BioSolutions unveiled a genetic precision medicine test for lupus patients that could predict heart disease before it happens.
Read More
One in Five Patients with Rheumatoid Arthritis were Undiagnosed During the Pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Read More
T2 Biosystems to Commercialize Test for Early Lyme Disease
T2 Biosystems plans to commercialize, a diagnostic test for early Lyme disease, with a goal of releasing it in the U.S. as an LDT in 2023.
Read More
Sebia Acquires Zeus Scientific
Sebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
Read More
Tool to Quickly Diagnose Tick-Borne Diseases Under Development
A team of researchers are ramping up and reimagining how medical professionals diagnose tick-borne infections such as Lyme disease.  Â
Read More
Bio-Techne Presents Initial Data on Sjögren’s Syndrome Monitoring Assay
Exosome Diagnostics presented data on their novel non-invasive saliva profiling assay for Sjögren’s Syndrome diagnosis and monitoring.
Read More
FDA Clears ImmunoCAP Blood Tests for Wheat & Sesame Allergy
The U.S. FDA cleared Thermo Fisher’s ImmunoCAP Specific IgE Allergen Components for wheat and sesame allergies for in vitro diagnostic use.
Read More